Chemed Corporation (NYSE:CHE) Receives $498.00 Average Price Target from Analysts

Chemed Corporation (NYSE:CHE) has earned a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $498.00.

Several analysts have issued reports on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research lowered shares of Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday. Royal Bank Of Canada restated a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Finally, Oppenheimer decreased their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th.

Institutional Investors Weigh In On Chemed

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Commonwealth Equity Services LLC increased its position in shares of Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares during the last quarter. WCM Investment Management LLC boosted its stake in Chemed by 3.8% during the third quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after buying an additional 24 shares during the period. Eukles Asset Management increased its position in shares of Chemed by 0.4% during the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after acquiring an additional 24 shares during the last quarter. Cim LLC raised its stake in shares of Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after acquiring an additional 24 shares during the period. Finally, Atria Investments Inc raised its stake in shares of Chemed by 0.6% in the 2nd quarter. Atria Investments Inc now owns 4,259 shares of the company’s stock valued at $2,074,000 after acquiring an additional 25 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 1.0%

Shares of NYSE CHE opened at $408.06 on Monday. The stock has a market cap of $5.62 billion, a PE ratio of 22.21, a P/E/G ratio of 1.63 and a beta of 0.46. Chemed has a 12-month low of $385.00 and a 12-month high of $623.60. The company has a 50-day moving average of $444.21 and a 200 day moving average of $442.86.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. During the same quarter in the prior year, the firm earned $6.83 earnings per share. The company’s revenue for the quarter was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, sell-side analysts forecast that Chemed will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio is currently 13.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.